Eiger BioPharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
EIGRQ on OTC
Location
2155 Park Boulevard, Palo Alto, CA

There are no Buy or Sell transactions made by insiders since 11/21/2023

Eiger BioPharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard A. Kayne 10%+ Owner $1.6M Oct 31, 2023
Leen Kawas 10%+ Owner $1.31M Oct 31, 2023
David A. Cory President and CEO, Director $50.4K Mar 11, 2022
Eldon C. Mayer III Ex VP & Chief Commerc. Officer $16.7K Mar 17, 2023
Sriram Ryali Chief Financial Officer $12.4K Mar 14, 2022
Ingrid Choong Chief Business Officer $9.97K Aug 31, 2023
Jeffrey S. Glenn Director Mar 1, 2023
Kim Sablich Director Mar 1, 2023
Amit Sachdev Director Mar 1, 2023
Christine Murray Director Mar 1, 2023
Lisa Kelly-Croswell Director Mar 1, 2023
James Vollins General Counsel Apr 30, 2023
Evan Loh Director Mar 1, 2023
Thomas Dietz Director Mar 1, 2023
William G. Kachioff Cfo Apr 12, 2023
Erik Atkisson GC & Chief Compliance Officer Jan 26, 2023
David Apelian CEO, Director Jul 3, 2023

Recent Insider Transactions by Companies or Individuals for Eiger BioPharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.